ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Nov. 03, 2025AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin thera ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback